|
Sign In to gain access to subscriptions and/or personal tools.
|
The Wnt Signaling Pathway in Bipolar Disorder
Todd D. Gould
Laboratory of Molecular Pathophysiology, National Institute of Mental Health Bethesda, Maryland
Husseini K. Manji
Laboratory of Molecular Pathophysiology, National Institute of Mental Health Bethesda, Maryland, manjih{at}intra.nimh.nih.gov
The Wnt signaling pathway is a highly conserved pathway critical for proper embryonic development. However, recent evidence suggests that this pathway and one of its key enzymes, glycogen synthase kinase 3β, may play important roles in regulating synaptic plasticity, cell survival, and circadian rhythms in the mature CNS—all of which have been implicated in the pathophysiology and treatment of bipolar disorder. Furthermore, two structurally highly dissimilar medications used to treat bipolar disorder, lithium and valproic acid, exert effects on components of the Wnt signaling pathway. Together, these data suggest that the Wnt signaling pathway may play an important role in the treatment of bipolar disorder. Here, the authors review the modulation of the Wnt/GSK-3β signaling pathway by mood-stabilizing agents, focusing on two therapeutically relevant aspects: neuroprotection and modulation of circadian rhythms. The future development of selective GSK-3β inhibitors may have considerable utility not only for the treatment of bipolar disorder but also for a variety of classical neurodegenerative disorders.
Key Words: Wnt signaling • Glycogen synthase kinase • Lithium • Valproic acid • Neuroprotection • Circadian rhythms • Bipolar disorder
The Neuroscientist, Vol. 8, No. 5,
497-511 (2002)
DOI: 10.1177/107385802237176
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
L. Chen, L. Zhang, Y. Zhao, L. Xu, Y. Shang, Q. Wang, W. Li, H. Wang, and X. Li
Prioritizing risk pathways: a novel association approach to searching for disease pathways fusing SNPs and pathways
Bioinformatics,
January 15, 2009;
25(2):
237 - 242.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. P. Zandi, P. L. Belmonte, V. L. Willour, F. S. Goes, J. A. Badner, S. G. Simpson, E. S. Gershon, F. J. McMahon, J. R. DePaulo Jr, J. B. Potash, et al.
Association Study of Wnt Signaling Pathway Genes in Bipolar Disorder
Arch Gen Psychiatry,
July 1, 2008;
65(7):
785 - 793.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Kitagawa, W. J. Ray, H. Glantschnig, P. V. Nantermet, Y. Yu, C.-T. Leu, S.-i. Harada, S. Kato, and L. P. Freedman
A Regulatory Circuit Mediating Convergence between Nurr1 Transcriptional Regulation and Wnt Signaling
Mol. Cell. Biol.,
November 1, 2007;
27(21):
7486 - 7496.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Csutora, A. Strassz, F. Boldizsar, P. Nemeth, K. Sipos, D. P. Aiello, D. M. Bedwell, and A. Miseta
Inhibition of phosphoglucomutase activity by lithium alters cellular calcium homeostasis and signaling in Saccharomyces cerevisiae
Am J Physiol Cell Physiol,
July 1, 2005;
289(1):
C58 - C67.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Quiroz, T. D. Gould, and H. K. Manji
MOLECULAR EFFECTS of lithium
Mol. Interv.,
October 1, 2004;
4(5):
259 - 272.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Du, N. A. Gray, C. A. Falke, W. Chen, P. Yuan, S. T. Szabo, H. Einat, and H. K. Manji
Modulation of Synaptic Plasticity by Antimanic Agents: The Role of AMPA Glutamate Receptor Subunit 1 Synaptic Expression
J. Neurosci.,
July 21, 2004;
24(29):
6578 - 6589.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. W. Doble and J. R. Woodgett
GSK-3: tricks of the trade for a multi-tasking kinase
J. Cell Sci.,
April 1, 2003;
116(7):
1175 - 1186.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
